Literature DB >> 16260066

A key role for the microglial NADPH oxidase in APP-dependent killing of neurons.

Bin Qin1, Laetitia Cartier, Michel Dubois-Dauphin, Bin Li, Lena Serrander, Karl-Heinz Krause.   

Abstract

Reactive oxygen species (ROS) and deposition of cleaved products of amyloid precursor protein (APP) are thought to contribute to neuronal loss observed in Alzheimer's disease (AD). The relationship between these factors was studied in a neuroblastoma and microglia co-culture system. Overexpression of wild-type APP (APP-wt) or APP with three mutations typical of familial AD (APP-3m) in SH-SY5Y neuroblastoma cells did not directly alter their morphology, growth rate, cell cycle or H(2)O(2) sensitivity. In a co-culture of APP-wt neuroblastoma cells with microglia, microglial cells generated ROS and neuronal cells died. The cell death was more pronounced in APP-3m-expressing neurons. Neuroblastoma cell death was attenuated by ROS-scavengers and was dose-dependently inhibited by the NADPH oxidase inhibitor diphenyleneiodonium chloride (DPI). Macrophage cell lines behaved similarly to microglia in the co-culture model. However, a macrophage cell line deficient in the NADPH oxidase subunit, gp91phox, failed to kill neurons. These results suggest that APP-dependent microglia activation and subsequent ROS generation by the phagocyte NADPH oxidase play a crucial role in neuronal killing in a cellular model of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260066     DOI: 10.1016/j.neurobiolaging.2005.09.036

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  38 in total

Review 1.  Reactive Oxygen Species: the Dual Role in Physiological and Pathological Conditions of the Human Body.

Authors:  Sanaa K Bardaweel; Mustafa Gul; Muhammad Alzweiri; Aman Ishaqat; Husam A ALSalamat; Rasha M Bashatwah
Journal:  Eurasian J Med       Date:  2018-10

Review 2.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 3.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

Review 4.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

5.  Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.

Authors:  J Vadnal; S Houston; S Bhatta; E Freeman; J McDonough
Journal:  Exp Brain Res       Date:  2012-07-19       Impact factor: 1.972

6.  RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia.

Authors:  Chao Shen; Yingjuan Ma; Ziling Zeng; Qingqing Yin; Yan Hong; Xunyao Hou; Xueping Liu
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

Review 7.  Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.

Authors:  Sarah Cahill-Smith; Jian-Mei Li
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

8.  NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia.

Authors:  Hideyuki Yoshioka; Kuniyasu Niizuma; Masataka Katsu; Nobuya Okami; Hiroyuki Sakata; Gab Seok Kim; Purnima Narasimhan; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-22       Impact factor: 6.200

9.  Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury.

Authors:  Kenji Dohi; Hirokazu Ohtaki; Tomoya Nakamachi; Sachiko Yofu; Kazue Satoh; Kazuyuki Miyamoto; Dandan Song; Shohko Tsunawaki; Seiji Shioda; Tohru Aruga
Journal:  J Neuroinflammation       Date:  2010-07-26       Impact factor: 8.322

10.  Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1.

Authors:  Séverine Boillée; Don W Cleveland
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.